Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rifamycins: strain improvement program

R Lal1, M Khanna, H Kaur

  • 1Department of Zoology, University of Delhi.

Critical Reviews in Microbiology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

Protease-driven approaches for wound eschar debridement and biofilm disruption: current advances, future prospects, and limitations.

Critical reviews in microbiology·2026
Same journal

Environmental regulation of pathogenicity islands by nucleoid-associated proteins in bacteria.

Critical reviews in microbiology·2026
Same journal

New strains, new threats: the rise of atypical non-typhoidal <i>Salmonella</i> serovars and what it means for global health.

Critical reviews in microbiology·2026
Same journal

Tripartite warfare: decoding the cell-virus-virophage arms race.

Critical reviews in microbiology·2026
Same journal

Anti-<i>Candida albicans</i> natural products: convergent technologies revolutionizing discovery from bioactivity assessment to targeted mechanisms.

Critical reviews in microbiology·2026
Same journal

Retraction Notice.

Critical reviews in microbiology·2026
See all related articles

Amycolatopsis mediterranei produces important rifamycin antibiotics. Genetic manipulation of this bacterium, including recombinant DNA techniques, has been crucial for improving antibiotic yields and developing new derivatives.

Area of Science:

  • Microbiology
  • Antibiotic Discovery
  • Genetic Engineering

Background:

  • Rifamycins are crucial antibiotics produced by Amycolatopsis mediterranei.
  • These antibiotics are vital for treating tuberculosis, leprosy, and other bacterial infections.
  • Strain improvement of A. mediterranei has been pursued since 1957 to enhance rifamycin production.

Purpose of the Study:

  • To review the genetic manipulation strategies for Amycolatopsis mediterranei.
  • To discuss traditional strain improvement methods and their limitations.
  • To highlight the advent of recombinant DNA techniques for A. mediterranei.

Main Methods:

  • Review of historical strain improvement techniques (mutations, recombination).
  • Discussion of the development of cloning vectors for A. mediterranei.

Related Experiment Videos

  • Explanation of transformation methods enabling genetic manipulation.

    • Main Results:

    • Traditional methods have limitations in optimizing rifamycin production.
    • Development of cloning vectors and transformation methods has enabled advanced genetic engineering.
    • Recombinant DNA techniques provide powerful tools for A. mediterranei strain development.

    Conclusions:

    • Genetic manipulation of Amycolatopsis mediterranei is essential for antibiotic production.
    • Recombinant DNA technology has significantly advanced the potential for rifamycin improvement.
    • Continued genetic engineering efforts are key to developing superior rifamycin-producing strains.